Why is Kobo Biotech falling/rising?

As of 10-Jul, Kobo Biotech Ltd's stock price is currently at 2.77, reflecting an increase of 0.13 or 4.92%. The stock has been on a positive trajectory, gaining for the last three days and achieving a total return of 15.42% during this period. It has outperformed its sector by 6.28% today. However, despite these short-term gains, the company faces significant challenges, including weak long-term fundamentals, as it has not declared results in the last six months, and its net sales have declined at an annual rate of -100.00%. Additionally, the company has a high debt-to-equity ratio, which raises concerns about its financial stability.
In the broader market context, Kobo Biotech's recent performance contrasts with the Sensex, which has shown a slight decline of 0.06% over the past week. While the stock has outperformed the benchmark in the short term, its long-term performance remains concerning, with a one-year return of -33.73% compared to the Sensex's gain of 4.09%. This disparity highlights the stock's volatility and the risks associated with investing in a company that has not demonstrated consistent growth or profitability.